INDIAN MARKET
 
INTERNATIONAL BUSINESS
 
 
Smart Pro-drug of Ampicillin & Sulbactam
  • Inhibit
  • s even plasmid mediated ESBLs
  • Does not cause cholestatic jaundice & hepatitis unlike Co-amoxyclav (use restricted by CSM, UK)
  • Pharmacokinetically fully compatible combination, unlike Co-amoxyclav

    In severe & recurrent Pharyngotonsillitis, Sinusitis, Suppurative Otitis Media, AECB, Pneumonia & SSTI

Outsmarts ß-lactamases

The ß-lactamases protected bactericidal
<< Previous Page